nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—PRKD1—chronic kidney failure	0.631	0.905	CbGaD
Crizotinib—CYP3A4—chronic kidney failure	0.0359	0.0516	CbGaD
Crizotinib—ABCB1—chronic kidney failure	0.0299	0.043	CbGaD
Crizotinib—BLK—blood—chronic kidney failure	0.00053	0.00451	CbGeAlD
Crizotinib—CSF1R—blood plasma—chronic kidney failure	0.000525	0.00448	CbGeAlD
Crizotinib—DCLK1—urethra—chronic kidney failure	0.000523	0.00446	CbGeAlD
Crizotinib—MAPK7—blood—chronic kidney failure	0.000507	0.00432	CbGeAlD
Crizotinib—TXK—blood—chronic kidney failure	0.000507	0.00432	CbGeAlD
Crizotinib—ACVR1B—gonad—chronic kidney failure	0.000504	0.00429	CbGeAlD
Crizotinib—FES—blood—chronic kidney failure	0.000502	0.00428	CbGeAlD
Crizotinib—MET—digestive system—chronic kidney failure	0.000499	0.00425	CbGeAlD
Crizotinib—TESK1—nephron tubule—chronic kidney failure	0.000494	0.00421	CbGeAlD
Crizotinib—FER—urethra—chronic kidney failure	0.000489	0.00416	CbGeAlD
Crizotinib—TNK1—urethra—chronic kidney failure	0.000483	0.00412	CbGeAlD
Crizotinib—EPHA6—gonad—chronic kidney failure	0.000481	0.00409	CbGeAlD
Crizotinib—IGF1R—renal system—chronic kidney failure	0.000478	0.00407	CbGeAlD
Crizotinib—MET—blood—chronic kidney failure	0.000475	0.00405	CbGeAlD
Crizotinib—PLK4—gonad—chronic kidney failure	0.000475	0.00404	CbGeAlD
Crizotinib—IGF1R—cardiovascular system—chronic kidney failure	0.000472	0.00402	CbGeAlD
Crizotinib—NUAK2—nephron tubule—chronic kidney failure	0.000468	0.00399	CbGeAlD
Crizotinib—FER—cortex of kidney—chronic kidney failure	0.000468	0.00399	CbGeAlD
Crizotinib—ACVR1—nephron tubule—chronic kidney failure	0.000465	0.00396	CbGeAlD
Crizotinib—MAP4K2—urethra—chronic kidney failure	0.000463	0.00394	CbGeAlD
Crizotinib—IGF1R—kidney—chronic kidney failure	0.000462	0.00393	CbGeAlD
Crizotinib—TIE1—cardiovascular system—chronic kidney failure	0.000459	0.00391	CbGeAlD
Crizotinib—TIE1—urethra—chronic kidney failure	0.000457	0.00389	CbGeAlD
Crizotinib—TAOK2—blood—chronic kidney failure	0.000456	0.00388	CbGeAlD
Crizotinib—AURKA—renal system—chronic kidney failure	0.000453	0.00386	CbGeAlD
Crizotinib—TESK1—renal system—chronic kidney failure	0.000449	0.00383	CbGeAlD
Crizotinib—FER—gonad—chronic kidney failure	0.000446	0.0038	CbGeAlD
Crizotinib—TYRO3—gonad—chronic kidney failure	0.000446	0.0038	CbGeAlD
Crizotinib—TESK1—urethra—chronic kidney failure	0.000441	0.00376	CbGeAlD
Crizotinib—JAK3—digestive system—chronic kidney failure	0.00044	0.00374	CbGeAlD
Crizotinib—AURKA—kidney—chronic kidney failure	0.000438	0.00373	CbGeAlD
Crizotinib—STK3—cortex of kidney—chronic kidney failure	0.000438	0.00373	CbGeAlD
Crizotinib—DCLK1—digestive system—chronic kidney failure	0.000437	0.00372	CbGeAlD
Crizotinib—STK4—digestive system—chronic kidney failure	0.000432	0.00368	CbGeAlD
Crizotinib—MERTK—urethra—chronic kidney failure	0.000429	0.00366	CbGeAlD
Crizotinib—IGF1R—gonad—chronic kidney failure	0.000428	0.00365	CbGeAlD
Crizotinib—TESK1—cortex of kidney—chronic kidney failure	0.000423	0.0036	CbGeAlD
Crizotinib—ACVR1—renal system—chronic kidney failure	0.000423	0.0036	CbGeAlD
Crizotinib—RIPK2—nephron tubule—chronic kidney failure	0.00042	0.00358	CbGeAlD
Crizotinib—JAK3—blood—chronic kidney failure	0.000419	0.00357	CbGeAlD
Crizotinib—ACVR1—cardiovascular system—chronic kidney failure	0.000418	0.00356	CbGeAlD
Crizotinib—FLT3—cardiovascular system—chronic kidney failure	0.000418	0.00356	CbGeAlD
Crizotinib—MAP3K12—urethra—chronic kidney failure	0.000415	0.00354	CbGeAlD
Crizotinib—ACVR1—urethra—chronic kidney failure	0.000415	0.00354	CbGeAlD
Crizotinib—PLK4—blood—chronic kidney failure	0.000414	0.00352	CbGeAlD
Crizotinib—STK4—blood—chronic kidney failure	0.000411	0.0035	CbGeAlD
Crizotinib—ACVR1—kidney—chronic kidney failure	0.000409	0.00348	CbGeAlD
Crizotinib—EPHA5—digestive system—chronic kidney failure	0.000408	0.00347	CbGeAlD
Crizotinib—ALK—digestive system—chronic kidney failure	0.000408	0.00347	CbGeAlD
Crizotinib—AURKA—gonad—chronic kidney failure	0.000406	0.00346	CbGeAlD
Crizotinib—TESK1—gonad—chronic kidney failure	0.000403	0.00343	CbGeAlD
Crizotinib—LIMK2—cortex of kidney—chronic kidney failure	0.000402	0.00343	CbGeAlD
Crizotinib—NUAK2—cortex of kidney—chronic kidney failure	0.000401	0.00342	CbGeAlD
Crizotinib—MAP3K2—nephron tubule—chronic kidney failure	0.000398	0.00339	CbGeAlD
Crizotinib—ACVR1—cortex of kidney—chronic kidney failure	0.000398	0.00339	CbGeAlD
Crizotinib—IGF1R—digestive system—chronic kidney failure	0.000392	0.00334	CbGeAlD
Crizotinib—TBK1—nephron tubule—chronic kidney failure	0.00039	0.00332	CbGeAlD
Crizotinib—PTK2—nephron tubule—chronic kidney failure	0.00039	0.00332	CbGeAlD
Crizotinib—ALK—blood—chronic kidney failure	0.000389	0.00331	CbGeAlD
Crizotinib—FER—blood—chronic kidney failure	0.000389	0.00331	CbGeAlD
Crizotinib—TYK2—nephron tubule—chronic kidney failure	0.000387	0.0033	CbGeAlD
Crizotinib—LYN—blood—chronic kidney failure	0.000387	0.00329	CbGeAlD
Crizotinib—PTK2B—renal system—chronic kidney failure	0.000385	0.00328	CbGeAlD
Crizotinib—TNK1—blood—chronic kidney failure	0.000385	0.00328	CbGeAlD
Crizotinib—LIMK2—gonad—chronic kidney failure	0.000383	0.00326	CbGeAlD
Crizotinib—IRAK1—nephron tubule—chronic kidney failure	0.000382	0.00326	CbGeAlD
Crizotinib—MAP4K1—blood—chronic kidney failure	0.000381	0.00324	CbGeAlD
Crizotinib—PTK2B—cardiovascular system—chronic kidney failure	0.000381	0.00324	CbGeAlD
Crizotinib—MAP3K12—gonad—chronic kidney failure	0.000379	0.00323	CbGeAlD
Crizotinib—FLT3—gonad—chronic kidney failure	0.000379	0.00323	CbGeAlD
Crizotinib—RIPK2—cardiovascular system—chronic kidney failure	0.000377	0.00321	CbGeAlD
Crizotinib—RIPK2—urethra—chronic kidney failure	0.000375	0.0032	CbGeAlD
Crizotinib—IGF1R—blood—chronic kidney failure	0.000373	0.00318	CbGeAlD
Crizotinib—PTK2B—kidney—chronic kidney failure	0.000372	0.00317	CbGeAlD
Crizotinib—AURKA—digestive system—chronic kidney failure	0.000372	0.00316	CbGeAlD
Crizotinib—STK35—gonad—chronic kidney failure	0.000371	0.00316	CbGeAlD
Crizotinib—MAP4K2—blood—chronic kidney failure	0.000368	0.00314	CbGeAlD
Crizotinib—STK3—blood—chronic kidney failure	0.000363	0.00309	CbGeAlD
Crizotinib—EPHA4—urethra—chronic kidney failure	0.000363	0.00309	CbGeAlD
Crizotinib—SLK—nephron tubule—chronic kidney failure	0.000358	0.00305	CbGeAlD
Crizotinib—BMP2K—gonad—chronic kidney failure	0.000358	0.00305	CbGeAlD
Crizotinib—EPHB4—nephron tubule—chronic kidney failure	0.000355	0.00302	CbGeAlD
Crizotinib—PTK2—renal system—chronic kidney failure	0.000355	0.00302	CbGeAlD
Crizotinib—TBK1—renal system—chronic kidney failure	0.000355	0.00302	CbGeAlD
Crizotinib—AURKA—blood—chronic kidney failure	0.000354	0.00301	CbGeAlD
Crizotinib—TYK2—renal system—chronic kidney failure	0.000352	0.003	CbGeAlD
Crizotinib—TESK1—blood—chronic kidney failure	0.000351	0.00299	CbGeAlD
Crizotinib—TBK1—cardiovascular system—chronic kidney failure	0.00035	0.00298	CbGeAlD
Crizotinib—PTK2—cardiovascular system—chronic kidney failure	0.00035	0.00298	CbGeAlD
Crizotinib—CYP3A4—urine—chronic kidney failure	0.00035	0.00298	CbGeAlD
Crizotinib—TBK1—urethra—chronic kidney failure	0.000348	0.00297	CbGeAlD
Crizotinib—PTK2—urethra—chronic kidney failure	0.000348	0.00297	CbGeAlD
Crizotinib—EPHA2—nephron tubule—chronic kidney failure	0.000348	0.00297	CbGeAlD
Crizotinib—TYK2—cardiovascular system—chronic kidney failure	0.000348	0.00296	CbGeAlD
Crizotinib—TYK2—urethra—chronic kidney failure	0.000346	0.00295	CbGeAlD
Crizotinib—PTK2B—gonad—chronic kidney failure	0.000345	0.00294	CbGeAlD
Crizotinib—PTK2—kidney—chronic kidney failure	0.000343	0.00292	CbGeAlD
Crizotinib—TBK1—kidney—chronic kidney failure	0.000343	0.00292	CbGeAlD
Crizotinib—MERTK—blood—chronic kidney failure	0.000341	0.00291	CbGeAlD
Crizotinib—RPS6KB1—renal system—chronic kidney failure	0.000341	0.00291	CbGeAlD
Crizotinib—TYK2—kidney—chronic kidney failure	0.000341	0.0029	CbGeAlD
Crizotinib—MAP3K3—nephron tubule—chronic kidney failure	0.00034	0.00289	CbGeAlD
Crizotinib—RPS6KB1—cardiovascular system—chronic kidney failure	0.000337	0.00287	CbGeAlD
Crizotinib—RPS6KB1—urethra—chronic kidney failure	0.000335	0.00285	CbGeAlD
Crizotinib—FGR—cardiovascular system—chronic kidney failure	0.000335	0.00285	CbGeAlD
Crizotinib—LIMK2—blood—chronic kidney failure	0.000334	0.00284	CbGeAlD
Crizotinib—TBK1—cortex of kidney—chronic kidney failure	0.000334	0.00284	CbGeAlD
Crizotinib—PTK2—cortex of kidney—chronic kidney failure	0.000334	0.00284	CbGeAlD
Crizotinib—AXL—cardiovascular system—chronic kidney failure	0.000334	0.00284	CbGeAlD
Crizotinib—LCK—urethra—chronic kidney failure	0.000333	0.00284	CbGeAlD
Crizotinib—FGR—urethra—chronic kidney failure	0.000333	0.00284	CbGeAlD
Crizotinib—NUAK2—blood—chronic kidney failure	0.000333	0.00283	CbGeAlD
Crizotinib—AXL—urethra—chronic kidney failure	0.000332	0.00283	CbGeAlD
Crizotinib—TYK2—cortex of kidney—chronic kidney failure	0.000332	0.00282	CbGeAlD
Crizotinib—EPHA4—gonad—chronic kidney failure	0.000331	0.00282	CbGeAlD
Crizotinib—MAP3K12—blood—chronic kidney failure	0.00033	0.00281	CbGeAlD
Crizotinib—FLT3—blood—chronic kidney failure	0.00033	0.00281	CbGeAlD
Crizotinib—ACVR1—blood—chronic kidney failure	0.00033	0.00281	CbGeAlD
Crizotinib—RPS6KB1—kidney—chronic kidney failure	0.00033	0.00281	CbGeAlD
Crizotinib—IRAK1—cortex of kidney—chronic kidney failure	0.000327	0.00279	CbGeAlD
Crizotinib—MAP3K2—gonad—chronic kidney failure	0.000325	0.00277	CbGeAlD
Crizotinib—EPHB4—renal system—chronic kidney failure	0.000323	0.00275	CbGeAlD
Crizotinib—RPS6KB1—cortex of kidney—chronic kidney failure	0.000321	0.00274	CbGeAlD
Crizotinib—JAK2—renal system—chronic kidney failure	0.00032	0.00273	CbGeAlD
Crizotinib—SLK—urethra—chronic kidney failure	0.000319	0.00272	CbGeAlD
Crizotinib—EPHB4—cardiovascular system—chronic kidney failure	0.000319	0.00272	CbGeAlD
Crizotinib—PTK2—gonad—chronic kidney failure	0.000318	0.00271	CbGeAlD
Crizotinib—TBK1—gonad—chronic kidney failure	0.000318	0.00271	CbGeAlD
Crizotinib—AXL—cortex of kidney—chronic kidney failure	0.000318	0.00271	CbGeAlD
Crizotinib—EPHB4—urethra—chronic kidney failure	0.000317	0.0027	CbGeAlD
Crizotinib—JAK2—cardiovascular system—chronic kidney failure	0.000317	0.0027	CbGeAlD
Crizotinib—PTK2B—digestive system—chronic kidney failure	0.000316	0.00269	CbGeAlD
Crizotinib—ABL2—blood—chronic kidney failure	0.000315	0.00269	CbGeAlD
Crizotinib—JAK2—urethra—chronic kidney failure	0.000315	0.00268	CbGeAlD
Crizotinib—YES1—nephron tubule—chronic kidney failure	0.000314	0.00267	CbGeAlD
Crizotinib—RIPK2—digestive system—chronic kidney failure	0.000313	0.00267	CbGeAlD
Crizotinib—EPHA2—cardiovascular system—chronic kidney failure	0.000313	0.00266	CbGeAlD
Crizotinib—EPHB4—kidney—chronic kidney failure	0.000312	0.00266	CbGeAlD
Crizotinib—BMP2K—blood—chronic kidney failure	0.000312	0.00265	CbGeAlD
Crizotinib—EPHA2—urethra—chronic kidney failure	0.000311	0.00265	CbGeAlD
Crizotinib—JAK2—kidney—chronic kidney failure	0.00031	0.00264	CbGeAlD
Crizotinib—TAOK3—nephron tubule—chronic kidney failure	0.00031	0.00264	CbGeAlD
Crizotinib—TEK—renal system—chronic kidney failure	0.000309	0.00263	CbGeAlD
Crizotinib—SLK—cortex of kidney—chronic kidney failure	0.000306	0.00261	CbGeAlD
Crizotinib—MAP3K3—cardiovascular system—chronic kidney failure	0.000305	0.0026	CbGeAlD
Crizotinib—TEK—cardiovascular system—chronic kidney failure	0.000305	0.0026	CbGeAlD
Crizotinib—EPHB4—cortex of kidney—chronic kidney failure	0.000304	0.00259	CbGeAlD
Crizotinib—TEK—urethra—chronic kidney failure	0.000303	0.00258	CbGeAlD
Crizotinib—MAP4K5—urethra—chronic kidney failure	0.000303	0.00258	CbGeAlD
Crizotinib—MAP3K3—urethra—chronic kidney failure	0.000303	0.00258	CbGeAlD
Crizotinib—AXL—gonad—chronic kidney failure	0.000303	0.00258	CbGeAlD
Crizotinib—JAK2—cortex of kidney—chronic kidney failure	0.000302	0.00257	CbGeAlD
Crizotinib—PTK2B—blood—chronic kidney failure	0.000301	0.00256	CbGeAlD
Crizotinib—TEK—kidney—chronic kidney failure	0.000299	0.00254	CbGeAlD
Crizotinib—RIPK2—blood—chronic kidney failure	0.000298	0.00254	CbGeAlD
Crizotinib—TBK1—digestive system—chronic kidney failure	0.000291	0.00248	CbGeAlD
Crizotinib—PTK2—digestive system—chronic kidney failure	0.000291	0.00248	CbGeAlD
Crizotinib—MAP4K5—cortex of kidney—chronic kidney failure	0.000291	0.00248	CbGeAlD
Crizotinib—MAP3K3—cortex of kidney—chronic kidney failure	0.000291	0.00248	CbGeAlD
Crizotinib—TEK—cortex of kidney—chronic kidney failure	0.000291	0.00248	CbGeAlD
Crizotinib—EPHB6—urethra—chronic kidney failure	0.00029	0.00247	CbGeAlD
Crizotinib—TYK2—digestive system—chronic kidney failure	0.000289	0.00246	CbGeAlD
Crizotinib—EPHA4—blood—chronic kidney failure	0.000289	0.00246	CbGeAlD
Crizotinib—JAK2—gonad—chronic kidney failure	0.000287	0.00245	CbGeAlD
Crizotinib—YES1—renal system—chronic kidney failure	0.000285	0.00243	CbGeAlD
Crizotinib—MAP3K2—blood—chronic kidney failure	0.000283	0.00241	CbGeAlD
Crizotinib—STK10—renal system—chronic kidney failure	0.000283	0.00241	CbGeAlD
Crizotinib—TAOK3—renal system—chronic kidney failure	0.000282	0.0024	CbGeAlD
Crizotinib—YES1—urethra—chronic kidney failure	0.00028	0.00239	CbGeAlD
Crizotinib—RPS6KB1—digestive system—chronic kidney failure	0.00028	0.00238	CbGeAlD
Crizotinib—STK10—cardiovascular system—chronic kidney failure	0.000279	0.00238	CbGeAlD
Crizotinib—TAOK3—cardiovascular system—chronic kidney failure	0.000278	0.00237	CbGeAlD
Crizotinib—FGR—digestive system—chronic kidney failure	0.000278	0.00237	CbGeAlD
Crizotinib—EPHB6—cortex of kidney—chronic kidney failure	0.000278	0.00237	CbGeAlD
Crizotinib—PTK2—blood—chronic kidney failure	0.000277	0.00236	CbGeAlD
Crizotinib—TBK1—blood—chronic kidney failure	0.000277	0.00236	CbGeAlD
Crizotinib—MAP4K5—gonad—chronic kidney failure	0.000277	0.00236	CbGeAlD
Crizotinib—MAP3K3—gonad—chronic kidney failure	0.000277	0.00236	CbGeAlD
Crizotinib—TAOK3—urethra—chronic kidney failure	0.000277	0.00236	CbGeAlD
Crizotinib—YES1—kidney—chronic kidney failure	0.000276	0.00235	CbGeAlD
Crizotinib—TYK2—blood—chronic kidney failure	0.000275	0.00234	CbGeAlD
Crizotinib—SRC—renal system—chronic kidney failure	0.000274	0.00234	CbGeAlD
Crizotinib—STK10—kidney—chronic kidney failure	0.000273	0.00233	CbGeAlD
Crizotinib—TAOK3—kidney—chronic kidney failure	0.000272	0.00232	CbGeAlD
Crizotinib—IRAK1—blood—chronic kidney failure	0.000272	0.00231	CbGeAlD
Crizotinib—SRC—cardiovascular system—chronic kidney failure	0.000271	0.00231	CbGeAlD
Crizotinib—YES1—cortex of kidney—chronic kidney failure	0.000269	0.00229	CbGeAlD
Crizotinib—RPS6KB1—blood—chronic kidney failure	0.000267	0.00227	CbGeAlD
Crizotinib—SRC—kidney—chronic kidney failure	0.000265	0.00226	CbGeAlD
Crizotinib—TAOK3—cortex of kidney—chronic kidney failure	0.000265	0.00226	CbGeAlD
Crizotinib—FGR—blood—chronic kidney failure	0.000265	0.00226	CbGeAlD
Crizotinib—LCK—blood—chronic kidney failure	0.000265	0.00226	CbGeAlD
Crizotinib—EPHB4—digestive system—chronic kidney failure	0.000265	0.00225	CbGeAlD
Crizotinib—JAK2—digestive system—chronic kidney failure	0.000263	0.00224	CbGeAlD
Crizotinib—EPHA2—digestive system—chronic kidney failure	0.00026	0.00221	CbGeAlD
Crizotinib—YES1—gonad—chronic kidney failure	0.000256	0.00218	CbGeAlD
Crizotinib—SLK—blood—chronic kidney failure	0.000254	0.00216	CbGeAlD
Crizotinib—STK10—gonad—chronic kidney failure	0.000253	0.00216	CbGeAlD
Crizotinib—EPHB4—blood—chronic kidney failure	0.000252	0.00215	CbGeAlD
Crizotinib—JAK2—blood—chronic kidney failure	0.00025	0.00213	CbGeAlD
Crizotinib—EPHA2—blood—chronic kidney failure	0.000247	0.00211	CbGeAlD
Crizotinib—SRC—gonad—chronic kidney failure	0.000246	0.0021	CbGeAlD
Crizotinib—CSF1R—cardiovascular system—chronic kidney failure	0.000243	0.00207	CbGeAlD
Crizotinib—CYP3A5—blood plasma—chronic kidney failure	0.000243	0.00207	CbGeAlD
Crizotinib—CSF1R—urethra—chronic kidney failure	0.000242	0.00206	CbGeAlD
Crizotinib—MAP3K3—blood—chronic kidney failure	0.000241	0.00206	CbGeAlD
Crizotinib—TEK—blood—chronic kidney failure	0.000241	0.00206	CbGeAlD
Crizotinib—MAP4K5—blood—chronic kidney failure	0.000241	0.00206	CbGeAlD
Crizotinib—YES1—digestive system—chronic kidney failure	0.000234	0.00199	CbGeAlD
Crizotinib—STK10—digestive system—chronic kidney failure	0.000232	0.00197	CbGeAlD
Crizotinib—TAOK3—digestive system—chronic kidney failure	0.000231	0.00197	CbGeAlD
Crizotinib—EPHB6—blood—chronic kidney failure	0.000231	0.00196	CbGeAlD
Crizotinib—SRC—digestive system—chronic kidney failure	0.000225	0.00192	CbGeAlD
Crizotinib—YES1—blood—chronic kidney failure	0.000223	0.0019	CbGeAlD
Crizotinib—CSF1R—gonad—chronic kidney failure	0.000221	0.00188	CbGeAlD
Crizotinib—STK10—blood—chronic kidney failure	0.000221	0.00188	CbGeAlD
Crizotinib—TAOK3—blood—chronic kidney failure	0.00022	0.00187	CbGeAlD
Crizotinib—SRC—blood—chronic kidney failure	0.000214	0.00183	CbGeAlD
Crizotinib—ABL1—nephron tubule—chronic kidney failure	0.000214	0.00182	CbGeAlD
Crizotinib—CSF1R—digestive system—chronic kidney failure	0.000202	0.00172	CbGeAlD
Crizotinib—ABL1—renal system—chronic kidney failure	0.000195	0.00166	CbGeAlD
Crizotinib—CSF1R—blood—chronic kidney failure	0.000193	0.00164	CbGeAlD
Crizotinib—ABL1—cardiovascular system—chronic kidney failure	0.000192	0.00164	CbGeAlD
Crizotinib—ABL1—urethra—chronic kidney failure	0.000191	0.00163	CbGeAlD
Crizotinib—ABL1—kidney—chronic kidney failure	0.000188	0.0016	CbGeAlD
Crizotinib—ABL1—cortex of kidney—chronic kidney failure	0.000183	0.00156	CbGeAlD
Crizotinib—CYP3A4—blood plasma—chronic kidney failure	0.000182	0.00155	CbGeAlD
Crizotinib—ABL1—gonad—chronic kidney failure	0.000175	0.00149	CbGeAlD
Crizotinib—ABL1—digestive system—chronic kidney failure	0.00016	0.00136	CbGeAlD
Crizotinib—ABL1—blood—chronic kidney failure	0.000152	0.0013	CbGeAlD
Crizotinib—ABCB1—blood plasma—chronic kidney failure	0.000129	0.0011	CbGeAlD
Crizotinib—CYP3A5—nephron tubule—chronic kidney failure	0.000125	0.00107	CbGeAlD
Crizotinib—CYP3A5—renal system—chronic kidney failure	0.000114	0.000971	CbGeAlD
Crizotinib—CYP3A5—kidney—chronic kidney failure	0.00011	0.000939	CbGeAlD
Crizotinib—CYP3A5—cortex of kidney—chronic kidney failure	0.000107	0.000914	CbGeAlD
Crizotinib—CYP3A5—digestive system—chronic kidney failure	9.35e-05	0.000796	CbGeAlD
Crizotinib—CYP3A5—blood—chronic kidney failure	8.91e-05	0.000759	CbGeAlD
Crizotinib—CYP3A4—renal system—chronic kidney failure	8.55e-05	0.000729	CbGeAlD
Crizotinib—CYP3A4—kidney—chronic kidney failure	8.27e-05	0.000704	CbGeAlD
Crizotinib—CYP3A4—digestive system—chronic kidney failure	7.02e-05	0.000598	CbGeAlD
Crizotinib—CYP3A4—blood—chronic kidney failure	6.68e-05	0.000569	CbGeAlD
Crizotinib—ABCB1—nephron tubule—chronic kidney failure	6.66e-05	0.000567	CbGeAlD
Crizotinib—ABCB1—renal system—chronic kidney failure	6.06e-05	0.000516	CbGeAlD
Crizotinib—ABCB1—cardiovascular system—chronic kidney failure	5.98e-05	0.00051	CbGeAlD
Crizotinib—ABCB1—urethra—chronic kidney failure	5.95e-05	0.000507	CbGeAlD
Crizotinib—ABCB1—kidney—chronic kidney failure	5.85e-05	0.000499	CbGeAlD
Crizotinib—ABCB1—cortex of kidney—chronic kidney failure	5.7e-05	0.000486	CbGeAlD
Crizotinib—ABCB1—gonad—chronic kidney failure	5.43e-05	0.000463	CbGeAlD
Crizotinib—ABCB1—digestive system—chronic kidney failure	4.97e-05	0.000423	CbGeAlD
Crizotinib—ABCB1—blood—chronic kidney failure	4.73e-05	0.000403	CbGeAlD
Crizotinib—SRC—Developmental Biology—TNF—chronic kidney failure	2.32e-06	1.25e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—EDN1—chronic kidney failure	2.32e-06	1.24e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	2.31e-06	1.24e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NOS3—chronic kidney failure	2.31e-06	1.24e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—IL6—chronic kidney failure	2.31e-06	1.24e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—LIPC—chronic kidney failure	2.31e-06	1.24e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP2C19—chronic kidney failure	2.31e-06	1.24e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IRS1—chronic kidney failure	2.3e-06	1.24e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—NOS3—chronic kidney failure	2.3e-06	1.24e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—KRAS—chronic kidney failure	2.3e-06	1.24e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—IL6—chronic kidney failure	2.3e-06	1.24e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCL5—chronic kidney failure	2.3e-06	1.24e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—KRAS—chronic kidney failure	2.3e-06	1.23e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—SERPINE1—chronic kidney failure	2.3e-06	1.23e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—IL6—chronic kidney failure	2.28e-06	1.22e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—IL6—chronic kidney failure	2.27e-06	1.22e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—IL6—chronic kidney failure	2.27e-06	1.22e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL1B—chronic kidney failure	2.27e-06	1.22e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ARG2—chronic kidney failure	2.26e-06	1.22e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—IL6—chronic kidney failure	2.26e-06	1.21e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—KRAS—chronic kidney failure	2.26e-06	1.21e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL1B—chronic kidney failure	2.26e-06	1.21e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—LPL—chronic kidney failure	2.25e-06	1.21e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—NFKB1—chronic kidney failure	2.24e-06	1.2e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—SERPINE1—chronic kidney failure	2.23e-06	1.2e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—IL6—chronic kidney failure	2.23e-06	1.2e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—LCAT—chronic kidney failure	2.22e-06	1.19e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—KRAS—chronic kidney failure	2.22e-06	1.19e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TGFB1—chronic kidney failure	2.22e-06	1.19e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—IL6—chronic kidney failure	2.21e-06	1.19e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—IL6—chronic kidney failure	2.21e-06	1.18e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—KRAS—chronic kidney failure	2.21e-06	1.18e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—KRAS—chronic kidney failure	2.21e-06	1.18e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—RELA—chronic kidney failure	2.21e-06	1.18e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NOS3—chronic kidney failure	2.19e-06	1.18e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—KRAS—chronic kidney failure	2.19e-06	1.18e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—RELA—chronic kidney failure	2.18e-06	1.17e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—F2—chronic kidney failure	2.17e-06	1.16e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—NFKB1—chronic kidney failure	2.17e-06	1.16e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—AVP—chronic kidney failure	2.16e-06	1.16e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—VEGFA—chronic kidney failure	2.15e-06	1.16e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—IL6—chronic kidney failure	2.13e-06	1.15e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—SCARB1—chronic kidney failure	2.13e-06	1.15e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NGF—chronic kidney failure	2.13e-06	1.14e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NOS3—chronic kidney failure	2.13e-06	1.14e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—IRS1—chronic kidney failure	2.13e-06	1.14e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL1B—chronic kidney failure	2.12e-06	1.14e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—VEGFA—chronic kidney failure	2.12e-06	1.14e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—NFKB1—chronic kidney failure	2.12e-06	1.14e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—SERPINE1—chronic kidney failure	2.11e-06	1.13e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTGS1—chronic kidney failure	2.11e-06	1.13e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—PTGS2—chronic kidney failure	2.11e-06	1.13e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—NFKB1—chronic kidney failure	2.11e-06	1.13e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—KRAS—chronic kidney failure	2.08e-06	1.12e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCR5—chronic kidney failure	2.07e-06	1.11e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—SREBF1—chronic kidney failure	2.07e-06	1.11e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—RELA—chronic kidney failure	2.06e-06	1.11e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—RELA—chronic kidney failure	2.06e-06	1.1e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—EDN1—chronic kidney failure	2.05e-06	1.1e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—KRAS—chronic kidney failure	2.05e-06	1.1e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IRS1—chronic kidney failure	2.05e-06	1.1e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—DDC—chronic kidney failure	2.04e-06	1.1e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCL5—chronic kidney failure	2.04e-06	1.09e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—KRAS—chronic kidney failure	2.03e-06	1.09e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—F2—chronic kidney failure	2.03e-06	1.09e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—VEGFA—chronic kidney failure	2.03e-06	1.09e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—NOS3—chronic kidney failure	2.02e-06	1.08e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—KRAS—chronic kidney failure	2.02e-06	1.08e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—HMGCR—chronic kidney failure	2.01e-06	1.08e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CAT—chronic kidney failure	2.01e-06	1.08e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—TGFB1—chronic kidney failure	2.01e-06	1.08e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—RELA—chronic kidney failure	2e-06	1.08e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—LPL—chronic kidney failure	1.99e-06	1.07e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—NFKB1—chronic kidney failure	1.98e-06	1.06e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	1.98e-06	1.06e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PRKD1—chronic kidney failure	1.98e-06	1.06e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	1.98e-06	1.06e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—POMC—chronic kidney failure	1.98e-06	1.06e-05	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	1.97e-06	1.06e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TGFB1—chronic kidney failure	1.97e-06	1.06e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—FASN—chronic kidney failure	1.97e-06	1.06e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—VEGFA—chronic kidney failure	1.97e-06	1.06e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ABCB1—chronic kidney failure	1.96e-06	1.05e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—KRAS—chronic kidney failure	1.95e-06	1.05e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TGFB1—chronic kidney failure	1.95e-06	1.05e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CCL2—chronic kidney failure	1.93e-06	1.04e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IRS1—chronic kidney failure	1.92e-06	1.03e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IGF1—chronic kidney failure	1.9e-06	1.02e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NGF—chronic kidney failure	1.89e-06	1.01e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—IL6—chronic kidney failure	1.87e-06	1.01e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—SERPINE1—chronic kidney failure	1.87e-06	1e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—IL6—chronic kidney failure	1.87e-06	1e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—LPL—chronic kidney failure	1.87e-06	1e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TGFB1—chronic kidney failure	1.86e-06	1e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—KRAS—chronic kidney failure	1.86e-06	9.99e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—NFKB1—chronic kidney failure	1.86e-06	9.99e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL1B—chronic kidney failure	1.86e-06	9.98e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SREBF2—chronic kidney failure	1.85e-06	9.96e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—POMC—chronic kidney failure	1.85e-06	9.93e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—PTGS2—chronic kidney failure	1.84e-06	9.91e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCR5—chronic kidney failure	1.83e-06	9.85e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NFKB1—chronic kidney failure	1.83e-06	9.85e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—KRAS—chronic kidney failure	1.83e-06	9.82e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP3A4—chronic kidney failure	1.83e-06	9.81e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—RELA—chronic kidney failure	1.82e-06	9.78e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCL2—chronic kidney failure	1.81e-06	9.72e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TGFB1—chronic kidney failure	1.81e-06	9.7e-06	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL6—chronic kidney failure	1.81e-06	9.7e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SERPINE1—chronic kidney failure	1.8e-06	9.69e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CYP1A1—chronic kidney failure	1.8e-06	9.68e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—KRAS—chronic kidney failure	1.8e-06	9.68e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ABCA1—chronic kidney failure	1.8e-06	9.64e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—IL6—chronic kidney failure	1.79e-06	9.64e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GCKR—chronic kidney failure	1.79e-06	9.62e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ABCC3—chronic kidney failure	1.79e-06	9.62e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—NOS3—chronic kidney failure	1.79e-06	9.59e-06	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL6—chronic kidney failure	1.78e-06	9.56e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IGF1—chronic kidney failure	1.78e-06	9.55e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—F2—chronic kidney failure	1.78e-06	9.55e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—LPIN1—chronic kidney failure	1.75e-06	9.41e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NFKB1—chronic kidney failure	1.74e-06	9.34e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—NFKB1—chronic kidney failure	1.73e-06	9.31e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—KRAS—chronic kidney failure	1.72e-06	9.26e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NOS3—chronic kidney failure	1.72e-06	9.25e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	1.72e-06	9.22e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—LRP2—chronic kidney failure	1.72e-06	9.22e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL6—chronic kidney failure	1.69e-06	9.07e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SERPINE1—chronic kidney failure	1.69e-06	9.07e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NFKB1—chronic kidney failure	1.69e-06	9.07e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—VEGFA—chronic kidney failure	1.69e-06	9.07e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IRS1—chronic kidney failure	1.68e-06	9.03e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—MTHFR—chronic kidney failure	1.68e-06	9.03e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—KRAS—chronic kidney failure	1.67e-06	8.98e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—KRAS—chronic kidney failure	1.67e-06	8.98e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—IL6—chronic kidney failure	1.67e-06	8.97e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—VEGFA—chronic kidney failure	1.66e-06	8.94e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—IL6—chronic kidney failure	1.65e-06	8.88e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PPARA—chronic kidney failure	1.65e-06	8.86e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL1B—chronic kidney failure	1.65e-06	8.84e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL6—chronic kidney failure	1.64e-06	8.81e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—PTGS2—chronic kidney failure	1.63e-06	8.77e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—KRAS—chronic kidney failure	1.63e-06	8.77e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—KRAS—chronic kidney failure	1.62e-06	8.73e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—RELA—chronic kidney failure	1.62e-06	8.71e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—POMC—chronic kidney failure	1.62e-06	8.7e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NOS3—chronic kidney failure	1.61e-06	8.66e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCL2—chronic kidney failure	1.58e-06	8.51e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—VEGFA—chronic kidney failure	1.58e-06	8.48e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—F2—chronic kidney failure	1.57e-06	8.45e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IGF1—chronic kidney failure	1.56e-06	8.37e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TGFB1—chronic kidney failure	1.55e-06	8.32e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—NFKB1—chronic kidney failure	1.54e-06	8.24e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—VEGFA—chronic kidney failure	1.53e-06	8.23e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TGFB1—chronic kidney failure	1.53e-06	8.21e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—KRAS—chronic kidney failure	1.53e-06	8.2e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—TGFB1—chronic kidney failure	1.52e-06	8.18e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CAT—chronic kidney failure	1.52e-06	8.16e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—RELA—chronic kidney failure	1.52e-06	8.15e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—IL6—chronic kidney failure	1.51e-06	8.13e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IRS1—chronic kidney failure	1.49e-06	8e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL6—chronic kidney failure	1.49e-06	7.99e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SERPINE1—chronic kidney failure	1.48e-06	7.94e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL6—chronic kidney failure	1.47e-06	7.88e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CPT1A—chronic kidney failure	1.46e-06	7.84e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TGFB1—chronic kidney failure	1.45e-06	7.78e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—KRAS—chronic kidney failure	1.44e-06	7.71e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—POMC—chronic kidney failure	1.43e-06	7.7e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—LIPC—chronic kidney failure	1.42e-06	7.64e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	1.42e-06	7.64e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—KRAS—chronic kidney failure	1.42e-06	7.6e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NOS3—chronic kidney failure	1.41e-06	7.58e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—KRAS—chronic kidney failure	1.41e-06	7.57e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—LPL—chronic kidney failure	1.41e-06	7.57e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TGFB1—chronic kidney failure	1.41e-06	7.56e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL6—chronic kidney failure	1.4e-06	7.54e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCL2—chronic kidney failure	1.4e-06	7.53e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IGF1—chronic kidney failure	1.38e-06	7.41e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NFKB1—chronic kidney failure	1.37e-06	7.35e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL6—chronic kidney failure	1.36e-06	7.31e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP1A1—chronic kidney failure	1.36e-06	7.31e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL6—chronic kidney failure	1.36e-06	7.3e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—POMC—chronic kidney failure	1.34e-06	7.22e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—KRAS—chronic kidney failure	1.34e-06	7.21e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—KRAS—chronic kidney failure	1.34e-06	7.19e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—TGFB1—chronic kidney failure	1.33e-06	7.16e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—RELA—chronic kidney failure	1.33e-06	7.14e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL6—chronic kidney failure	1.33e-06	7.13e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL6—chronic kidney failure	1.32e-06	7.1e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SCARB1—chronic kidney failure	1.31e-06	7.06e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SERPINE1—chronic kidney failure	1.31e-06	7.03e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—KRAS—chronic kidney failure	1.3e-06	7e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTGS1—chronic kidney failure	1.3e-06	6.99e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NFKB1—chronic kidney failure	1.28e-06	6.87e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SREBF1—chronic kidney failure	1.28e-06	6.85e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MTHFR—chronic kidney failure	1.27e-06	6.81e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NOS3—chronic kidney failure	1.25e-06	6.71e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PPARA—chronic kidney failure	1.24e-06	6.68e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL6—chronic kidney failure	1.24e-06	6.67e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—VEGFA—chronic kidney failure	1.24e-06	6.67e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HMGCR—chronic kidney failure	1.24e-06	6.66e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—KRAS—chronic kidney failure	1.24e-06	6.63e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ALB—chronic kidney failure	1.23e-06	6.58e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—FASN—chronic kidney failure	1.21e-06	6.52e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—KRAS—chronic kidney failure	1.18e-06	6.36e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—TGFB1—chronic kidney failure	1.18e-06	6.34e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—RELA—chronic kidney failure	1.18e-06	6.32e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—NOS3—chronic kidney failure	1.17e-06	6.3e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL6—chronic kidney failure	1.17e-06	6.27e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—VEGFA—chronic kidney failure	1.16e-06	6.24e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL6—chronic kidney failure	1.15e-06	6.18e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—IL6—chronic kidney failure	1.15e-06	6.16e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TGFB1—chronic kidney failure	1.14e-06	6.12e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NFKB1—chronic kidney failure	1.12e-06	6.02e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ABCA1—chronic kidney failure	1.11e-06	5.94e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—KRAS—chronic kidney failure	1.09e-06	5.87e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL6—chronic kidney failure	1.09e-06	5.87e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL6—chronic kidney failure	1.09e-06	5.85e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTGS2—chronic kidney failure	1.07e-06	5.76e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TGFB1—chronic kidney failure	1.07e-06	5.73e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL6—chronic kidney failure	1.06e-06	5.69e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—KRAS—chronic kidney failure	1.06e-06	5.67e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—VEGFA—chronic kidney failure	1.02e-06	5.46e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—POMC—chronic kidney failure	1.01e-06	5.45e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—IL6—chronic kidney failure	1e-06	5.4e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NFKB1—chronic kidney failure	9.92e-07	5.33e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—KRAS—chronic kidney failure	9.88e-07	5.3e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL6—chronic kidney failure	9.64e-07	5.17e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CAT—chronic kidney failure	9.36e-07	5.03e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TGFB1—chronic kidney failure	9.34e-07	5.02e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ALB—chronic kidney failure	9.25e-07	4.97e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ABCB1—chronic kidney failure	9.11e-07	4.89e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—VEGFA—chronic kidney failure	9.01e-07	4.84e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—IL6—chronic kidney failure	8.9e-07	4.78e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—NOS3—chronic kidney failure	8.85e-07	4.75e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—LPL—chronic kidney failure	8.68e-07	4.66e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—KRAS—chronic kidney failure	8.65e-07	4.65e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL6—chronic kidney failure	8.59e-07	4.61e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	8.38e-07	4.5e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TGFB1—chronic kidney failure	8.27e-07	4.44e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTGS2—chronic kidney failure	8.09e-07	4.35e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL6—chronic kidney failure	8.03e-07	4.32e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MTHFR—chronic kidney failure	7.81e-07	4.2e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PPARA—chronic kidney failure	7.67e-07	4.12e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—KRAS—chronic kidney failure	7.66e-07	4.11e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL6—chronic kidney failure	7.04e-07	3.78e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—POMC—chronic kidney failure	6.25e-07	3.36e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL6—chronic kidney failure	6.23e-07	3.35e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALB—chronic kidney failure	5.7e-07	3.06e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—NOS3—chronic kidney failure	5.45e-07	2.93e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTGS2—chronic kidney failure	4.98e-07	2.68e-06	CbGpPWpGaD
